Abstract
ImuVert is a biological response modifier (BRM) that has antitumor effects in humans and rats. The influence of ImuVert on the ganglioside composition of two experimental brain tumors, ependymoblastoma and CT-2A, was studied in C57BL/6J mice. Gangliosides are expressed on plasma membranes and can serve as markers to distinguish neural cells from nonneural cells in mouse brain tumors.N- acetylneuraminic (NeuAc) is the predominant sialic acid in mouse neural cells, whereasN-glycolylneuraminic (NeuGc) is a major sialic acid in nonneural cells, e.g., macrophages and lymphocytes. ImuVert treatment increased the NeuGc ganglioside concentration in the ependymoblastoma, but had no effect on the sialic acid concentration in the CT-2A brain tumor. ImuVert also had a slight inhibitory effect on the growth of both brain tumors.
Similar content being viewed by others
Abbreviations
- BRM:
-
biological response modifier
- HPTLC:
-
high-performance thin-layer chromatography
- INF:
-
interferon
- ip:
-
intraperitoneal
- NeuAc:
-
N-acetylneuraminic acid
- NeuGc:
-
N-glycolylneuraminic acid
- 20-MC:
-
20-methylcholanthrene
References
Ando S., Chang N.C., and Yu R. K. (1978) High performance thin layer chromatography and densitometric determination of brain ganglioside compositions of several species.Anal. Biochem. 89, 437–450.
Bai H., Orlando J., and Seyfried T. N. (1992) Altered ganglioside composition in virally transformed rat embryo fibroblasts.Biochim. Biophys. Acta 1136, 23–27.
Cunningham-Rundles S. and Pearson F. C. (1990) ImuVert activation of natural killer cytotoxicity and interferon gamma production via CD16 triggering.Int. J. Immunopharm. 12, 589–598.
Elmslie R. E., Ogilvie G. K., Dow S. W., Gasper P., Hoover E. A., Cooper M. F., and Pearson F. C. (1991) Evaluation of a biological response modifier derived fromSerratia marcescens: effects on feline macrophages and usefulness for the prevention and treatment of viremia in feline leukemia virus-infected cats.Mol. Biother. 3, 231–238.
Evans R. and Eidlen M. (1981) Macrophage accumulation in transplanted tumors is not dependent on host immune responsiveness or presence of tumorassociated rejection antigens.J. Reticuloend. Soc. 30, 425–437.
Flavin H. J., Wieraszako A., and Seyfried T. N. (1991) Enhanced aspartate release from hippocampal slices of epileptic (El) mice.J. Neurochem. 56, 1007–1011.
Hakamori S. I. and Kannagi R. (1983) Glycosphingolipids as tumor-associated and differentiation markers.J. Nat. Cancer Inst. 71, 231–251.
Hoon D. S. B., Okun E., Banez M., Reiko F. I., and Morton D. L. (1991) Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.Cancer Res. 51, 5687–5693.
Jaeckle K. A., Mittelman A., and Hill F. H. (1990) Phase II trial ofSerratia marcescens extract in recurrent malignant astrocytomas.J. Clin. Oncol. 8, 1408–1418.
Jimenez J. J., McCall C.A., Cirocco R. E., and Yunis A.A. (1990) Treatment with ImuVert aborts development of chloroleukemia in newborn rats.J. Biol. Resp. Mod. 9, 300–304.
Looney W. B., Mayo A. A., Allen P. M., Morrow J. Y., and Morris H. P. (1973) A mathematical evaluation of tumour growth curves in rapid, intermediate and slow growing rat hepatoma.Br. J. Cancer 27, 341–344.
McCall C., Weimer L., Campbell P., Riches D., and Urban R. (1988) Macrophage activation induced by a biological response modifier derived fromSerratia marcescens.J. Cell Biochem. 12E (suppl.), 175.
McCall C. A., Weimer L., Baldwin S., and Pearson F. C. (1989) Biotherapy: a new dimension in cancer treatment.Bio/Technology 7, 231–240.
Mercurio A. M., Schwarting G. A., and Robbins P. W. (1984) Glycolipids of the mouse peritoneal macrophage. Alterations in amount and surface exposure of specific glycolipid species in response to inflammation and tumoricidal activation.J. Exp. Med. 160, 1114–1125.
Morantz R. A., Wood G. W., Foster M., Clark M., and Gollahon M. S. (1979a) Macrophages in experimental and human brain tumors. Part 1.J. Neurosurg. 50, 298–304.
Morantz R. A., Wood G. W., Foster M., Clark M., and Gollahon M. S. (1979b) Macrophages in experimental and human brain tumors. Part 2.J. Neurosurg. 50, 305–311.
Ridley A. and Cavanagh J. B. (1971) Lymphocytic infiltration in gliomass: evidence of possible host resistance.Brain 94, 117–124.
Rossi M. L., Esiri M. M., Jones N. R., Coakham H. B., Moss T. H., Cruz-Sanchez F. F., and Carey M. P. (1991) Characterization of the mononuclear cell infiltrate and HLA-Dr expression in 19 oligodendrogliomas.Surg. Neurol. 3, 119–125.
Rubin R., Sutton C. H., and Zimmerman H. M. (1968) Experimental ependymoblastoma (fine structure).J. Neuropathol. Exp. Neurol. 42, 1–15.
Schauer R. (1985) Sialic acids and their roles as biological masks.Trends Biochem. Sci. 10, 357–360.
Schiffer D., Chio A., Giordana M. T., Mauro A., Migheli A., and Vigliani M. C. (1989) The vascular response to tumor infiltration in malignant gliomas.Acta Neuropath. (Berl.) 77, 369–378.
Schwarting G. A. and Gajewski A. (1983) Glycolipids of murine lymphocyte subpopulations.J. Biol. Chem. 258, 5693–5698.
Seyfried T. N., Glaser G. H., and Yu R. K. (1978) Cerebral, cerebellar, and brain stem gangliosides in mice susceptible to audiogenic seizures.J. Neurochem. 31, 21–27.
Seyfried T. N., Itoh T., Glaser G. H., Miyazawa N., and Yu R. K. (1981) Cerebellar gangliosides and phospholipids in mutant mice with ataxia and epilepsy: the tottering/leaner syndrome.Brain Res. 216, 429–436.
Seyfried T. N., Yu R. K., Saito M., and Albert M. (1987) Ganglioside composition of an experimental mouse brain tumor.Cancer Res. 47, 3538–3542.
Seyfried T. N., El-Abbadi M., and Roy M. L. (1992) Ganglioside distribution in murine neural tumors.Mol. Chem. Neuropathol. 17, 147–167.
Shinonaga M., Chang C. C., Suzuki N., Sato M., and Kuwabara T. (1988) Immunohistological evaluation of macrophage infiltrates in brain tumors.J. Neurosurg. 68, 259–265.
Siddiqui B. and Young K. S. (1984) Effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on glycolopids of human rectal adenocarcinoma cells.Cancer Res. 44, 1648–1652.
Svennerholm L. (1957) Quantitative estimation of sialic acids.Biochim. Biophys. Acta 24, 604–612.
Warren R. P., McCall C. A., and Urban R. W. (1989) Augmentation of natural killer cell activity by ImuVert: a biological response modifier derived fromSerratia marcescens.Mol. Biother. 1, 145–151.
Weisenthal L. M., Dill P. L., and Pearson F. C. (1991) Effect of prior cancer chemotherapy on human tumor-specific cytoxicity in vitro in response to immunopotentiating biologic response modifiers.J. Nat. Cancer Inst. 83, 37–42.
Yates A. J. (1988) Glycolipids and gliomas: A review.Neurochem. Pathol. 8, 157–179.
Yates A. J., Stephens R. E., Markowitz D. L., Elder P. J., Sirinek L. P., and Whisler M. D. (1985) Resistance to natural killer cytolysis and neutral glycolipid composition of cultured human glioma and fetal brain cells.J. Neuropathol. Exp. Neurol. 44, 371–383.
Yates A. J., Markowitz D. L., Stephens R. E., Pear D. K., and Whisler R. L. (1988) Growth inhibition of cultured human glioma cells by beta-interferon is not dependent on changes in ganglioside composition.J. Neuropathol. Exp. Neurol. 47, 119–127.
Yohe H. C. and Ryan J. L. (1986) Ganglioside expression in macrophages from endotoxin responder and nonresponder mice.J. Immunol. 137, 3921–3927.
Yohe H. C., Coleman D. L., and Ryan J. L. (1985) Ganglioside alterations in stimulated murine macrophages.Biochim. Biophys. Acta 818, 81–86.
Yohe H. C., Cuny C. L., Macala L. J., Saito M., McMurray W. J., and Ryan, J. L. (1991) The presence of sialidase-sensitive sialosylgangliotetraosyl ceramide (GM1b) in stimulated murine macrophages.J. Immunol. 146, 1900–1908.
Yu R. K. and Ledeen R. W. (1970) Gas-liquid chromatographic assay of lipid-bound sialic acids: measurement of gangliosides in brains of several species.J. Lipid Res. 11, 506–516.
Zimmerman H. M. and Arnold H. (1941) Experimental brain tumors: 1. Tumors produced with methylcholanthrene.Cancer Res. 1, 919–938.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cotterchio, M., Seyfried, T.N. The influence of ImuVert, a biological response modifier, on the growth and ganglioside composition of murine neural tumors. Molecular and Chemical Neuropathology 20, 163–172 (1993). https://doi.org/10.1007/BF02815369
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02815369